VNRX

VolitionRX Limited (VNRX)

About VolitionRX Limited (VNRX)

VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. The company was founded on September 24, 1998 and is headquartered in Henderson, NV.

Details

Daily high
$0.57
Daily low
$0.55
Price at open
$0.56
52 Week High
$1.02
52 Week Low
$0.43
Market cap
53.1M
Dividend yield
0.00%
Volume
57,755
Avg. volume
111,182
P/E ratio
-1.54

VolitionRX Limited News

Details

Daily high
$0.57
Daily low
$0.55
Price at open
$0.56
52 Week High
$1.02
52 Week Low
$0.43
Market cap
53.1M
Dividend yield
0.00%
Volume
57,755
Avg. volume
111,182
P/E ratio
-1.54